In the 17th CPhI that just ends the reporter on the meeting learns, for recover lost territory, italy begins to sponsor a series of technical barrier measure in the light of India and China in European Union interior from last year, active to medicaments part introduces such as but date from system and execute label of country of origin to wait to raw material medicine.
Long-standing
Italian place media " 24 hours of suns sign up for " last year ever gave to this matter in the news June 25 report. This report says, situation of trade of production of drug of Italian raw material is grim 2005, turnover is 3 billion euro only. Predicted to grow 1% 2006, but still cannot compete with the company of production of raw material drug of China and India.
On the global API seminar that 13-16 day will hold in Italian Milan last year in June, association of medicine of Italianize eductional systme also showed similar angst sentiment fully: In the near future, raw material medicine of Europe produces the global market share of business to drop year after year, replace will be the growth that Asian enterprise stabilizes continuously, and the person that India serves as among them outstanding, will make the whole world at replacing Italy 2010 medicine of the 2nd big raw material produces a country.
The raw material medicine that serves as old brand exports a nation, raw material medicine exports a be Italian medicine industry undoubtedly important pillar, accordingly, face afore-mentioned menace, adopt necessary step to answer become urgent matter.
As we have learned, besides introduce but date from system and execute label of country of origin to wait to raw material medicine offer besides, italy still was referred to European Union authorities strengthen wait for an opinion to importing raw material to examine and approve and be superintended of medicine. Arrive to the entrance especially the raw material medicine of the European Union, italy thinks, should strengthen the spot examination to importing an enterprise.
And before this, because place of manpower material resources is restricted, the European Union did not execute spot examination entirely to importer. Also capture an European Union just about superintending this one flaw that go up, italy serves as his recapture afresh in former days the weapon of the market.
The influence cannot be ignored
To afore-mentioned behavior of Italy, cure protects chamber of commerce relevant controller warns a company: Its risk and influence cannot be ignored.
This controller expresses, although our country exports the raw material medicine of the European Union, although do not have the spot inspection that passes European Union authorities, a lot of quality also are pass a barrier, but spot check checks the standard that promotes us the business also is to have profit greatly. And, latter west media often has a few negative stories that export in the light of medicine of our country raw material, because this expects very hard,the European Union will take relevant step henceforth.
Previous12 Next
Previous:Capsule of American Niu Mansi DHA enters China
Next：Nepalese already 50 much people die at disease of acute bowel path this year
Next：Nepalese already 50 much people die at disease of acute bowel path this year
Related Articles- Medicines and chemical reagents of
- New discovery of European the Thre
- French new discovery avian flu dou
- Congo (gold) area of the eastpart
- Nepalese already 50 much people di
- Medicine of pillar industry raw ma
- Capsule of American Niu Mansi DHA
- Area of British great majority is
- Heart scientist suffers the depart
- Korea is bred admirable sweet Ai C
Hot Concern- Medicine of pillar industry raw ma
- Capsule of American Niu Mansi DHA
- Korea is bred admirable sweet Ai C
- Heart scientist suffers the depart
- Area of British great majority is
- Nepalese already 50 much people di
- Congo (gold) area of the eastpart
- French new discovery avian flu dou
- New discovery of European the Thre
- Medicines and chemical reagents of
Disclaimer:The only purpose of the site is to deliver more information. This dose not mean that the site will agree with the views and be responsible for its authenticity.